Package 50090-7423-0

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50090-7423-0
Digits Only 5009074230
Product NDC 50090-7423
Product ID 50090-7423_fac39d5b-b46e-4035-9f8b-5cbf0cbcecc0
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7423-0)

Marketing

Marketing Status
Marketed Since 2024-10-28
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fac39d5b-b46e-4035-9f8b-5cbf0cbcecc0", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["a724b3b6-f60e-4b88-8603-8141a32075da"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7423-0)", "package_ndc": "50090-7423-0", "marketing_start_date": "20241028"}], "brand_name": "Bupropion hydrochloride", "product_id": "50090-7423_fac39d5b-b46e-4035-9f8b-5cbf0cbcecc0", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-7423", "generic_name": "Bupropion hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA216800", "marketing_category": "ANDA", "marketing_start_date": "20230531", "listing_expiration_date": "20261231"}